Iradimed's market cap is currently $945.99M. The company's EPS TTM is $0.49; its P/E ratio is 46.12; and it has a dividend yield of 0.86%. Iradimed is scheduled to report earnings on August 1, 2025, and the estimated EPS forecast is $0.46. See an overview of income statement, balance sheet, and cash flow financials.
